Clinical Trials Browser

Interventional × Hepatitis C × 1 year × Clear all

NCT03520660 2026-04-14

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

NCT01022476 2026-04-06

LIVERAL

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT07038863 2025-06-26

Mondelta

Phase NA Not yet recruiting

Gastrointestinal

Hepatitis D, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease